Cardiometabolic Disease
Genetic risk scores for insulin resistance tied to cardiometabolic measures for children
Genetic risk scores for predicting insulin resistance that were developed for adults are also tied to some cardiometabolic metrics in children and adolescents, according to study findings.
Cardiometabolic drugs consume majority of cost among those up for price negotiation
Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications consumed more than 80% of Medicare Part D spending, researchers reported.
The year in obesity: New data on semaglutide and tirzepatide, sarcopenic obesity and more
New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering glucose levels and body weight.
CMHC to provide ‘exciting’ updates spanning cardio-kidney-metabolic sector
The 19th annual Cardiometabolic Health Congress will be held at the Boston Park Plaza and will feature the latest science in the areas of cardio-renal, obesity, diabetes and dyslipidemia, atherosclerosis, thrombosis and more.
Novel oral drug linked to weight loss in people with obesity, metabolic syndrome
Novo Nordisk announced that monlunabant, a novel small molecule oral cannabinoid receptor 1 inverse agonist, was associated with weight loss in a phase 2a study of people with obesity and metabolic syndrome.
Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases
Adults who drink caffeinated beverages such as coffee or tea may have a lower risk for developing multiple cardiometabolic diseases compared with adults with low or no intake, according to study findings.
Healio wins APEX award for Treating Obesity resource center
The Healio news team won an APEX Grand Award for its Treating Obesity resource center, a collection of the latest news and perspectives on medications for obesity.
Q&A: New initiative to address CKM syndrome, affecting millions in the US
In October 2023, the American Heart Association unveiled the term cardiovascular-kidney-metabolic syndrome to reflect the connection between metabolic and renal conditions associated with risk for heart disease.
Aim to lower cardiometabolic disease risk when considering dietary pattern for obesity
PHILADELPHIA — Some dietary change may improve cardiometabolic measures beyond weight loss and providers should create a diet that will most benefit each individual with obesity, according to a speaker.
‘This is going to take all of us’: Creative partnerships can reduce cardiometabolic risk
BOSTON — Lowering cardiovascular risk for people with type 2 diabetes requires effort from far beyond the clinician’s office, leveraging creative community partnerships that address social determinants of health, according to a speaker.